Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Park Systems is a South Korea-based public company that develops and sells nanoscale microscopy and metrology systems, with a core focus on atomic force microscopy (AFM). Its product portfolio spans research and industrial AFM systems as well as adjacent metrology technologies including white light interferometry, nano-infrared spectroscopy, imaging spectroscopic ellipsometry, digital holographic microscopy, and active vibration isolation. The company serves customers across semiconductors, materials science, energy, and life sciences, where its instruments are used for high-resolution surface characterization, biomolecular and cellular imaging, and process metrology. Park Systems is not a drug developer; rather, it is a commercial instrumentation supplier whose healthcare relevance comes from enabling life-science research and related analytical workflows. The company has expanded its platform through acquisitions including Accurion and Lyncée Tec.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Park Systems.